12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, health care stocks showed significant movement. Adial Pharmaceuticals (ADIL) and NKGen Biotech (NKGN) led the gainers with over 30% increases in their stock prices, while Vaxxinity (VAXX) and Hepion Pharmaceuticals (HEPA) were among the top losers, with VAXX stock dropping over 60%. The movements were attributed to various factors, including recent earnings reports for some companies.
April 22, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Hepion Pharmaceuticals stock declined by 37.82% to $1.25, following their Q4 earnings report 4 days ago.
The negative reaction to HEPA's recent Q4 earnings report suggests concerns among investors, potentially leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Vaxxinity stock declined by 61.3% to $0.18, with a market cap of $23.3 million.
The drastic drop in VAXX's stock price could indicate negative investor sentiment or reactions to recent company developments, likely leading to further short-term volatility.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 90
POSITIVE IMPACT
Adial Pharmaceuticals stock rose 34.2% to $2.59, with a market cap of $10.5 million.
The significant pre-market increase in ADIL's stock price could attract more investor interest, potentially leading to short-term price volatility.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
NKGen Biotech shares surged 32.0% to $1.46, following their Q4 earnings report 4 days ago.
NKGN's recent earnings report likely contributed to the positive investor sentiment, driving up its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90